Individual Response to Different Volumes of Resistance Training

Determinants of Intra-individual Variation in Adaptability to Resistance Training of Different Volumes

The literature is not clear as to which training volume to employ during initial phases of resistance training programs to ensure optimal muscular adaptations. The purpose of this study is therefore to compare effects of strength training with low versus moderate volume on muscular function and hypertrophy in previously untrained, healthy individuals. Furthermore, the investigators will relate individual variation in responses to proxy markers of individual training state, such as baseline muscular function and muscle fiber type.

The study will include 25 women and 25 men and will consist of a 12-week resistance training protocol. Each study participant will act as their own control, performing both the low- (1-set) and the moderate-volume (3-sets) protocol, allocated to either the dominant or non-dominant leg, in a stratified and randomized fashion.

Primary outcome measures are thigh muscle cross section area and unilateral knee extension strength. Additionally, muscle fiber type composition will be evaluated as well as additional parameters of muscular function.

The primary hypothesis is that low-volume protocols will be beneficial for individuals with glycolytic muscle phenotypes, whereas the opposite will be true for individuals with more aerobic phenotypes.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lillehammer, Norway
        • Lillehammer University College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy
  • Non-smoking
  • Able to tolerate resistance exercise training

Exclusion Criteria:

  • Presence or history of cardiovascular, metabolic, endocrine or neuromuscular disease
  • Diagnosed mental health disorder
  • Intolerance to local anesthetic
  • No experience with exercise training
  • Performing regular resistance training (more than 1 session per week during last 12 months)
  • Impaired strength/ neuromuscular function due to previous injury
  • Recurrent pain in lower back, knee or shoulders
  • Taking prescribed medication that may affect outcome of training intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm label 1-Set, 3-Set
12-week progressive strength training protocol of different volumes
Every study participant will complete 12 weeks of progressive strength training with one leg performing 1-set per exercise per session and the contralateral leg performing 3-sets per exercise per session. Allocation of dominant/non-dominant leg to either 1- or 3-set protocol will be done in a stratified, randomized fashion (stratified with regard to sex and baseline strength).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thigh muscle cross-sectional area
Time Frame: Week 0 (baseline) and 12 (post training intervention)
Changes in muscle cross sectional area of each thigh from baseline to post intervention, assessed by MRI.
Week 0 (baseline) and 12 (post training intervention)
Unilateral knee-extension isometric strength
Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
Time course changes in maximum knee extensor, isometric strength evaluated at 120° knee angle (180° fully extended).
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle strength
Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
Time course changes in maximum isoinertial strength defined by one-repetition maximum in leg press, knee extension, knee flexion, and bench press.
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
Knee extensors and flexors force-velocity relationship
Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
Time course changes in torque measured during maximal voluntary isokinetic contraction at 60°, 120° and 240° ∙ sec-1.
Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)
Blood hormonal profiles
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
Resting (week 0, 2 and 12) and acutely exercise-induced (week 2) hormonal profiles (testosterone, insulin-like growth factor 1, growth hormone and cortisol) determined in serum from venous blood samples.
Week 0 (baseline), 2 and 12 (post training intervention)
Muscle fiber cross-sectional area
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
Changes in muscle fiber cross-sectional area assessed by immunohistochemistry from muscle biopsy. Determined from muscle biopsy samples (Vastus lateralis).
Week 0 (baseline), 2 and 12 (post training intervention)
Protein expression
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
Changes in relative abundance of contractile protein isoforms (myosin heavy chain). Modification of proteins related to muscle hypertrophy in relation to an acute exercise session (assessed during week 2 of the intervention). Determined from muscle biopsy samples (Vastus lateralis).
Week 0 (baseline), 2 and 12 (post training intervention)
Gene expression
Time Frame: Week 0 (baseline), 2 and 12 (post training intervention)
Changes in gene expression related to skeletal muscle hypertrophy and structural phenotype measured in steady state conditions (biopsy sampled in resting conditions, week 0, 2 and 12) and in relation to acute exercise (biopsy sampled 1-h after strength exercise, week 2). Determined from muscle biopsy samples (Vastus lateralis).
Week 0 (baseline), 2 and 12 (post training intervention)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition changes
Time Frame: Week 0 (baseline) and 12 (post training intervention)
Changes in body compositions (lean mass and fat mass) from prior intervention to after intervention assessed by dual x-ray absorptiometry scan.
Week 0 (baseline) and 12 (post training intervention)
Habitual physical activity
Time Frame: Week 0
Self-reported prior habitual physical activity assessed by questionnaire and interview before training intervention
Week 0
Daily nutrient intake
Time Frame: Week 6
Daily nutrient intake assessed by a 4-day food intake registration.
Week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stian Ellefsen, PhD, Inland Norway University of Applied Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

June 27, 2014

First Submitted That Met QC Criteria

June 30, 2014

First Posted (Estimate)

July 1, 2014

Study Record Updates

Last Update Posted (Estimate)

November 6, 2015

Last Update Submitted That Met QC Criteria

November 5, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on 12-week progressive strength training protocol

Subscribe